Fig. 7

Correlation with therapeutic response in breast cancer. (A–C) Differential expression of (A) immunotherapy-predicted pathways, (B) therapeutic signatures, and (C) IC50 of chemotherapy drugs in high and low LIMCH1 groups. Significance indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Power analysis results indicated as # power > 0.95, ## power > 0.99, ### power > 0.999, #### power > 0.9999.